Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1999, p. 26-30, Vol. 37, No. 1
Departments of Medical
Microbiology2 and
Internal
Medicine,1 University of Manitoba, and
St. Boniface General Hospital,3
Winnipeg, Manitoba, Canada
Received 20 May 1998/Returned for modification 27 July
1998/Accepted 29 September 1998
Viridans group streptococci (VGS) are commonly isolated from the
blood of hospitalized patients. The E test represents a convenient method for determining the MICs for VGS, but for this purpose it has
not been well validated against reference methods. In this study, 180 unselected VGS isolates were identified to a species level, and the
MICs of penicillin, cefuroxime, cefotaxime, and vancomycin were
determined by both agar dilution and the E test. Available data
regarding demographic and laboratory variables for each VGS bacteremic
episode were collected, the significance of each VGS isolate was
assessed, and the associations between and among laboratory and
clinical variables were investigated. Among all VGS isolates, 68.3%
(median of three runs) were found to be fully susceptible to penicillin
by agar dilution. The E test and agar dilution showed average
agreements (within ±1 dilution) of 92.2% for penicillin, 95.7% for
cefuroxime 91.3% for cefotaxime, and 86.7% for vancomycin. Agreements
over serial E tests and serial agar dilutions were excellent for
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
E Test versus Agar Dilution for Antimicrobial
Susceptibility Testing of Viridans Group Streptococci
-lactam agents (intraclass correlation coefficients, >0.9) but less
impressive for vancomycin. Very major error rates for the E test were
0.7%, and combined major and minor error rates were within
acceptable limits for all antimicrobial agents tested.
Lysis-centrifugation culture methods were more often associated with
clinically insignificant VGS isolates; otherwise, no associations
between clinical and laboratory variables were noted.
*
Corresponding author. Mailing address: Department of
Medical Microbiology, St. Boniface General Hospital, L4025, 409 Taché Ave., Winnipeg, MB R2H 2A6, Phone: (204) 237-2657. Fax:
(204) 233-7125. E-mail: malfa{at}cc.umanitoba.ca.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»